|
|
January
19,
2009 -- 7:20pm EST
When Less is More: Stents, That Is
So many
news reports about the recent FAME
study in the New
England Journal of Medicine drive home a message that is not
exactly correct. The "Stents May Be Overused" headline is misleading.
And here's why.
Yes, the FAME
study did show that when FFR (Fractional Flow Reserve) was used
routinely to measure whether or not a coronary lesion was ischemic,
less stents were implanted per patient, and the resulting
decrease in major cardiac events was significant.
But stenting, as an important therapy, was never called
into question. The patient population for the FAME study consisted
of patients with multivessel disease -- and 94% of these patients
had stents implanted. Yes, that's 94%! It's just that the number
of stents per
patient was
lower, on the average: two stents instead of three.
In
fact Nico Pijls, the co-principal investigator for FAME, told Angioplasty.Org
that, rather than reduce the total number of stents used, the use
of FFR could easily expand the patient population that could benefit
by stents. For example,
patients with
multiple blockages might only have only 2 that are measured as ischemic,
and
thus would be candidates for stenting, rather than surgery.
He characterized the FAME results as a refinement of stenting, and that
they actually may expand the use of the procedure as well.
You can read Angioplasty.Org's exclusive interview with
Dr. Pijls here.
|
|
|